Alzheimer's Disease and Mild Cognitive Impairment

Research on the pathophysiology of Alzheimer's disease (AD) has indicated that there is an element of inflammation involved in the degenerative process. Since this element of inflammation may influence the progression of the disease and hence the symptoms, several studies have been undertaken t...

Full description

Saved in:
Bibliographic Details
Published inThe Wiley Handbook on the Aging Mind and Brain pp. 445 - 482
Main Authors Jones, David T, Bruns, Marla B, Petersen, Ronald C
Format Book Chapter
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 18.04.2018
Subjects
Alzheimer's disease
antipsychotic medications
mild cognitive impairment
neuropsychological testing
pharmacologic treatment
psychiatric symptoms
Online AccessGet full text

Cover

More Information
Summary:Research on the pathophysiology of Alzheimer's disease (AD) has indicated that there is an element of inflammation involved in the degenerative process. Since this element of inflammation may influence the progression of the disease and hence the symptoms, several studies have been undertaken to determine the possible efficacy of anti‐inflammatories in treating AD. Atypical clinical presentations of AD occur with initial prominent symptoms in visual‐spatial abilities, language, or executive functioning. However, these are much less common than the typical memory‐predominate presentation. Neuropsychological testing can help determine if the subject is experiencing cognitive changes of normal aging or the earliest signs of AD or possibly mild cognitive impairment (MCI). In general, atypical antipsychotic medications are preferred in the treatment of psychosis in AD because of a better side effect profile. Implicit in a discussion of AD and MCI is knowledge about cognitive changes in normal aging.
ISBN:111877177X
9781118771778
DOI:10.1002/9781118772034.ch21